Stock message boards
MNV
Market News Video
MNV MNV 10 Oversold Stocks You Need To Know About
MNV
MNV
MNV
MNV
MNV
MNV
MNV
Free Dividend Report - Top Ranked Stocks

Featured MNV Articles:

ARIAD Pharmaceuticals (ARIA) Shares Cross Above 200 DMA
Thursday, July 24, 11:54 AM ET, by Market News Video Staff

In trading on Thursday, shares of ARIAD Pharmaceuticals, Inc. (ARIA) crossed above their 200 day ...

Spectrum Pharmaceuticals Becomes Oversold (SPPI)
Friday, July 25, 12:19 PM ET, by Market News Video Staff

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy ...

Use Options For a Chance To Buy BCRX at a 65% Discount
Monday, July 28, 11:43 AM ET, by Market News Video Staff

Looking back to 61 days ago, BioCryst Pharmaceuticals, Inc. (BCRX) priced a $100,000,000 secondary stock ...

SPDR S&P Biotech ETF Experiences Big Inflow
Thursday, July 31, 11:00 AM ET, by Market News Video Staff

Symbols mentioned in this story: XBI, INSM, INO, EXEL Exchange traded funds (ETFs) trade just ...

Relative Strength Alert For Insmed
Monday, August 4, 12:19 PM ET, by Market News Video Staff

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy ...

  More articles:  1 2 3 4 5 6 7 next »

Theravance Inc Breaks Above 200-Day Moving Average - Bullish for THRX

By Market News Video Staff, Thursday, January 10, 4:42 PM ET
Play Video: Learn About The 200 DMA


If the video does not load after a few moments, Upgrade to the Latest Flash Player.

In trading on Thursday, shares of Theravance Inc (NASDAQ:THRX) crossed above their 200 day moving average of $23.41, changing hands as high as $23.56 per share. Theravance Inc shares are currently trading up about 3.6% on the day. The chart below shows the one year performance of THRX shares, versus its 200 day moving average:

Theravance Inc 200 Day Moving Average Chart

Looking at the chart above, THRX's low point in its 52 week range is $15.69 per share, with $31.87 as the 52 week high point that compares with a last trade of $23.51.


Special Offer: Find out what Dave Moenning is holding in the ETF Channel Flexible Growth Investment Portfolio with 30 Days Free.

According to the ETF Finder at ETF Channel, THRX makes up 3.18% of the SPDR S&P Biotech ETF (AMEX:XBI) which is trading up by about 0.1% on the day Thursday.

See what other ETFs contain THRX
See what other stocks are held by XBI


Top Six Most Viewed Stories This Week @ Market News Video:

This Article's Word Cloud:   AMEX   According   Biotech   Channel   Crossing   Dave   Days   Definition   Definitions   ETFs   Earnings   Exchange   Finder   Fund   Growth   Looking   Price   SPDR   Special   Start   Stocks   THRX   Their   Theravance   Thursday   Traded   about   above   average   below   changing   chart   currently   held   high   makes   moving   other   point   range   raquo   share   shares   that   trading   versus   week   what   which   with
MNV
MNV
About Us - Advertise - Contact Us - Embedding Videos - Licensing Videos - Partners - mRSS / RSS Feed - Terms of Use - Privacy Policy - Video Widget
MNV
Home  |  Analyst News  Dividend Report  Econonomic News  Insider Report  Large Caps  Market Movers  Week Ahead Report  Weekly Market Wrap
MNV
MNV MNV Stock Message Boards Stock Market Definitions
MNV

Theravance Inc Breaks Above 200-Day Moving Average - Bullish for THRX | Market News Video | Copyright © 2008 - 2014, All Rights Reserved

Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners. In no way should any content contained herein be interpreted to represent trading or investment advice. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.